Modafinil 57237-0155
Product NDC
57237-0155- Manufacturer
- Rising Pharma Holdings, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- September 27, 2012
- Listing Expires
- December 31, 2026
- Application
- ANDA202566
Active Ingredients
| Ingredient | Strength |
|---|---|
| Modafinil | 200 mg/1 |
Drug Class
Sympathomimetic-like Agent [EPC]Central Nervous System Stimulation [PE]Increased Sympathetic Activity [PE]
Packaging Options(3)
100 TABLET in 1 BOTTLE (57237-155-01)
30 TABLET in 1 BOTTLE (57237-155-30)
90 TABLET in 1 BOTTLE (57237-155-90)